Newswise — HOUSTON ― The James P. Allison Institute at The University of Texas MD Anderson Cancer Center today announced the appointment of its newest members, Susan Bullman, Ph.D.
, and Xi Chen, Ph.D., to further the institute’s ongoing work of impactful immunobiology research.
These accomplished researchers, joining as associate members, bring valuable expertise in studying how the intratumoral microbiome and the immune microenvironment influence patient responses to immunotherapy . As Allison Institute members , Bullman and Chen will lead impactful research programs aligned with the institute’s priority focus areas and with MD Anderson’s mission to end cancer. Both are focused on pushing the field beyond understanding and manipulating the interaction between T cells and cancer cells toward multiple integrated areas that influence tumor immunity.
“We are committed to bringing in the world’s top minds to advance our work toward gaining a comprehensive understanding of the tumor immune response, and we are pleased to welcome Drs. Bullman and Chen to MD Anderson and to the Allison Institute,” said James P. Allison, Ph.
D. , director of the Allison Institute and regental professor and chair of Immunology at MD Anderson. “Both are leaders in their respective fields, and their unique expertise opens new avenues to our understanding of immunobiology that will help further our work to bring the benefits of immunotherapy to all patients.
” All members are approved b.
